We have detected that you are using some form of ad-blocking or filtering.
, a bio/informatics shared resource is still "open for business" - Visit the CDS website
Renal cell carcinoma is a heterogeneous disease, and tissue investigations provide clues that may predict treatment response. Oncogenomic analysis of five outliers, who achieved a sustained response with rapalogs, implicates alterations of the TSC1 and mTOR genes and reveals insights into the conserved evolution of tumors.
Released February 29, 2020